Position in JNJ
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$627,813
+$72,446 QoQ
Shares Held
2,472
+8.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#3,469
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GILL CAPITAL PARTNERS, LLC holds $2,047,361 across 12 Drug Manufacturers - General names. JNJ ranks #1 (30.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
2,472 | $627,813 | |
| 2 | LLY |
ELI LILLY & Co
|
516 | $618,905 | |
| 3 | ABBV |
AbbVie Inc.
|
1,590 | $400,107 | |
| 4 | AMGN |
Amgen Inc
|
291 | $105,376 | |
| 5 | MRK |
Merck & Co., Inc.
|
766 | $98,431 | |
| 6 | PFE |
Pfizer Inc
|
2,993 | $72,071 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
865 | $49,841 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
338 | $42,702 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $627,813 | 2,472 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $555,367 | 2,272 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $470,190 | 2,272 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $451,312 | 2,434 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $361,253 | 2,365 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $375,130 | 2,262 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $313,536 | 2,168 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $306,131 | 1,889 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $278,288 | 1,904 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $304,515 | 1,925 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $301,724 | 1,925 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $296,548 | 1,904 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $317,963 | 1,921 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $297,445 | 1,919 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $346,940 | 1,964 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $316,918 | 1,940 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $349,162 | 1,967 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $348,611 | 1,967 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $380,801 | 2,226 | Shares | Sole | 2022-03-10 | |
| 2021-09-30 | $307,657 | 1,905 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $263,913 | 1,602 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $312,922 | 1,904 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $252,122 | 1,602 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $238,505 | 1,602 | Shares | Sole | 2021-02-02 | |
| 2020-06-30 | $242,024 | 1,721 | Shares | Sole | 2021-02-02 | |
| 2020-03-31 | $245,475 | 1,872 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||